Delivering biologics via oral administration represents a growing market that is expected to exhibit 35% CAGR from 2023–2028.

Kraig Biocraft Laboratories has developed transgenic silkworms to produce spider silk in commercial quantities.

Knowledge extraction: Through the application of AI and knowledge graphs, Wisecube were able to explore repurposed drugs for ...

SmartLabs’ new Custom Developed Solutions (CDS) platform provides specialized oversight and hands-on expertise in the design, ...

Enveda’s pipeline is led by ENV-294, a first-in-class, oral small molecule being developed to treat atopic dermatitis and other inflammatory conditions by combining the advantages of blockbuster drugs ...

Thaysen stepped in to lead Illumina through a tumultuous time, and now—as this GEN interview relates—he is carrying out his near- and long-term plans for the company.